Insider · CIK 0001190273
Norbert W Bischofberger
directorowner
Files at VIR (Vir Biotechnology, Inc.), KRON (Kronos Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | KRON Kronos Bio, Inc. | UTender of shares Common Stockindirect: See Footnote | -10,802,138 | $0.57 | $6.2M | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | UTender of shares Common Stockindirect: See Footnote | -263,750 | $0.57 | $150k | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | UTender of shares Common Stockindirect: See Footnote | -263,750 | $0.57 | $150k | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | UTender of shares Common Stockindirect: See Footnote | -263,750 | $0.57 | $150k | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | UTender of shares Common Stockindirect: See Footnote | -263,750 | $0.57 | $150k | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -297,186 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -400,000 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -570,868 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 20, 2025 | KRON Kronos Bio, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -699,800 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 6, 2025 | VIR Vir Biotechnology, Inc. | JOther Common Stock | -10,667 | $0.00 | $0 | 13,333 | Jun 6, 2025 |
| Jun 6, 2025 | VIR Vir Biotechnology, Inc. | JOther Common Stockindirect: See footnote | +10,667 | $0.00 | $0 | 10,667 | Jun 6, 2025 |
| May 30, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 24,000 | Jun 2, 2025 |
| May 30, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.